Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
LILiminatus Pharma, Inc. logo

Liminatus Pharma, Inc. (LIMN)

NASDAQ Global Select · Currency in USD
$3.16 ▲ +0.22 (+7.48%)
At close: Oct 26, 4:00 PM ET. Market closed.
$2.91 ▼ -0.25 (-7.91%)
After hours: Oct 26, 4:10 PM ET

Summary

Previous Close
$2.94
Open
$3.05
Day's Range
$2.73 – $3.25
52 Week Range
$2.91 – $141.50
Volume
9,366
Avg. Volume
487,253
Market Cap
$4.24M
Beta (5Y Monthly)
0.75
PE Ratio (TTM)
--
EPS (TTM)
-$26.36
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Liminatus Pharma, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
1
CEO
Chris Kim

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.

Earnings

DateEst.Actual
Aug 14, 2026–-$1.50
May 15, 2026–-$0.03
Mar 31, 2026–-$0.03
Nov 13, 2025–-$0.07
Oct 3, 2025–$0.25
May 31, 2025–-$127.50

Get free alerts on LIMN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.